Rebound macular edema following oral acetazolamide therapy for juvenile X-linked retinoschisis in an Italian family

被引:14
作者
Galantuomo, Maria Silvana [1 ]
Fossarello, Maurizio [1 ]
Cuccu, Alberto [1 ]
Farci, Roberta [1 ]
Preising, Markus N. [2 ]
Lorenz, Birgit [2 ]
Napoli, Pietro Emanuele [1 ]
机构
[1] Univ Cagliari, Eye Clin, Dept Surg Sci, Cagliari, Italy
[2] Univ Giessen, Fac Med, Dept Ophthalmol, Giessen, Germany
关键词
juvenile X-linked retinoschisis; oral acetazolamide; topical dorzolamide; cystoid macular edema; macular schisis; foveal zone thickness;
D O I
10.2147/OPTH.S114568
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Juvenile X-linked retinoschisis (RS1, OMIM: 312700) is a hereditary vitreoretinal dystrophy characterized by bilateral foveal schisis and, in half of the patients, splitting through the nerve fiber layer in the peripheral retina. In the first decade of life, patients usually develop a decrease in visual acuity. Long-term visual outcomes can be poor due to the limited number of known successful treatments. Purpose: The purposes of this study were to present, for the first time, a p.Arg197Cys missense mutation in the RS1 gene (OMIM: 300839) in a four-generation Italian family with RS1 and to examine the clinical response to the treatment with acetazolamide tablets alone or in combination with dorzolamide eye drops as assessed by spectral-domain optical coherence tomography (SD-OCT). Methods: Eleven individuals, including two brothers with RS1 (patients 1 and 2), underwent a full medical history examination and a comprehensive ocular assessment that involved SD-OCT, fluorescein angiography, electroretinography and DNA analysis. Each RS1 patient received oral acetazolamide (375 mg daily) during the first three months. Thereafter, patient 1 continued only with dorzolamide eyedrops three times a day for a period of three months, while patient 2 spontaneously stopped both medications. Results: Sequence analysis of the RS1 gene identified a hemizygous c.589C.T (p.Arg197Cys) missense mutation in exon 6, which has not been previously reported in an Italian family. A different response to the medical therapy was observed in the four eyes of the two affected brothers hemizygous for this abnormality. Of note, after acetazolamide interruption, a rebound effect on cystoid macular edema reduced the beneficial effects of the initial therapy for RS1 from p.Arg197Cys mutation. Indeed, a minimal rebound effect on cystoid macular edema, and an improvement in visual acuity, was observed in patient 1 during the six months of treatment. Conversely, in patient 2, an initial improvement in cystoid macular edema was not associated with visual acuity changes, followed by a marked rebound effect. Conclusion: This study showed that the sequential use of acetazolamide tablets and dorzolamide eye drops should be considered and studied further as a possible treatment for macular edema and visual impairment in patients with RS1 from a hemizygous p.Arg197Cys mutation.
引用
收藏
页码:2377 / 2382
页数:6
相关论文
共 23 条
[1]   Use of dorzolamide for patients with X-linked retinoschisis [J].
Apushkin, Marsha A. ;
Fishman, Gerald A. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (07) :741-745
[2]   Resolution of Mid-Peripheral Schisis in X-Linked Retinoschisis with the Use of Dorzolamide [J].
Collison, Frederick T. ;
Genead, Mohamed A. ;
Fishman, Gerald A. ;
Stone, Edwin M. .
OPHTHALMIC GENETICS, 2014, 35 (02) :125-127
[3]   Retinal Dystrophy with Intraretinal Cystoid Spaces Associated with Mutations in the Crumbs Homologue (CRB1) Gene [J].
Cordovez, Jose A. ;
Traboulsi, Elias I. ;
Capasso, Jenina E. ;
Sadagopan, Karthikeyan Arcot ;
Ganesh, Anuradha ;
Rychwalski, Paul J. ;
Neely, Kimberly A. ;
Brodie, Scott E. ;
Levin, Alex V. .
OPHTHALMIC GENETICS, 2015, 36 (03) :257-264
[4]   The APOSTEL recommendations for reporting quantitative optical coherence tomography studies [J].
Cruz-Herranz, Andres ;
Balk, Lisanne J. ;
Oberwahrenbrock, Timm ;
Saidha, Shiv ;
Martinez-Lapiscina, Elena H. ;
Lagreze, Wolf A. ;
Schuman, Joel S. ;
Villoslada, Pablo ;
Calabresi, Peter ;
Balcer, Laura ;
Petzold, Axel ;
Green, Ari J. ;
Paul, Friedemann ;
Brandt, Alexander U. ;
Albrecht, Philipp .
NEUROLOGY, 2016, 86 (24) :2303-2309
[5]   Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography [J].
Drexler, W ;
Sattmarin, H ;
Hermann, B ;
Ko, TH ;
Stur, M ;
Unterhuber, A ;
Scholda, C ;
Findl, O ;
Wirtitsch, M ;
Fujimoto, JG ;
Fercher, AF .
ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (05) :695-706
[6]   Efficacy of Sustained Topical Dorzolamide Therapy for Cystic Macular Lesions in Patients With X-Linked Retinoschisis [J].
Genead, Mohamed A. ;
Fishman, Gerald A. ;
Walia, Saloni .
ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (02) :190-197
[7]   Acetazolamide in the treatment of X-linked retinoschisis maculopathy [J].
Ghajarnia, Mehdi ;
Gorin, Michael B. .
ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (04) :571-573
[8]   Acetazolamide in Retinoschisis: A Prospective Study [J].
Gurbaxani, Avinash ;
Wei, Michael ;
Succar, Tony ;
McCluskey, Peter J. ;
Jamieson, Robyn V. ;
Grigg, John R. .
OPHTHALMOLOGY, 2014, 121 (03) :802-803
[9]   X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotype [J].
Khandhadia, S. ;
Trump, D. ;
Menon, G. ;
Lotery, A. J. .
EYE, 2011, 25 (07) :921-927
[10]   Genetic and clinical evaluation of juvenile retinoschisis [J].
Kim, Judy E. ;
Ruttum, Mark S. ;
Koeberl, Matthew J. ;
Hassemer, Eryn L. ;
Sidjanin, D. J. .
JOURNAL OF AAPOS, 2009, 13 (02) :215-217